Position in ANIP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,283,928
+$2,353,166 QoQ
Shares Held
232,954
+5.8% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 305 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. ANIP ranks #12 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in ANIP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,283,928 | 232,954 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $16,930,762 | 220,166 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $19,314,247 | 244,670 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $11,825,192 | 129,096 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $17,156,507 | 262,935 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $28,303,110 | 422,750 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $14,817,802 | 268,050 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $33,101,453 | 554,835 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $13,626,308 | 213,981 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $16,051,292 | 232,190 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $12,352,626 | 224,023 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $5,446,781 | 93,813 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,909,939 | 91,212 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,729,368 | 43,539 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $1,573,474 | 39,112 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,143,123 | 35,567 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,050,643 | 35,411 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $796,467 | 28,334 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,481,332 | 32,147 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,149,618 | 35,028 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,923,156 | 54,869 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,127,488 | 58,868 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,563,628 | 53,844 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $215,015 | 7,622 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $217,679 | 6,731 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $277,071 | 6,801 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||